Comparative analysis of KRAS codon 12, 13, 18, 61 and 117 mutations using human MCF10A isogenic cell lines
B. Stolze(Universität Ulm), Claudia Scholl(German Cancer Research Center)
Cited by 132
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|136
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions
|Nature Communications|2024|27
Multidimensional Characterization of Soft-Tissue Sarcomas with FUS-TFCP2 or EWSR1-TFCP2 Fusions
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1